VANGUARD GROUP INC - CHINOOK THERAPEUTICS INC ownership

CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 139 filers reported holding CHINOOK THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of CHINOOK THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$113,268,498
+71.8%
2,948,165
+3.5%
0.00%
+50.0%
Q1 2023$65,927,380
-9.9%
2,847,835
+2.0%
0.00%0.0%
Q4 2022$73,165,439
+55.1%
2,792,574
+16.4%
0.00%
+100.0%
Q3 2022$47,180,000
+14.2%
2,399,766
+1.6%
0.00%0.0%
Q2 2022$41,321,000
+38.1%
2,362,576
+29.1%
0.00%0.0%
Q1 2022$29,928,000
+2.7%
1,829,372
+2.4%
0.00%0.0%
Q4 2021$29,139,000
+59.2%
1,786,514
+24.5%
0.00%
Q3 2021$18,306,000
-6.8%
1,434,696
+3.2%
0.00%
Q2 2021$19,636,000
+4.8%
1,390,610
+15.3%
0.00%
-100.0%
Q1 2021$18,735,000
-0.0%
1,205,567
+2.0%
0.00%0.0%
Q4 2020$18,739,0001,181,5360.00%
Other shareholders
CHINOOK THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Parallel Advisors, LLC 5$00.00%
View complete list of CHINOOK THERAPEUTICS INC shareholders